Clinical Trials in Salt Lake City

Showing 7941-7960 of 12,670 trials

Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

NCT02270944

The purpose of the present study is to assess and compare in healthy non-pregnant women 18 to 40 years of age the safety and immunogenicity of a liquid formulation of Group B Streptococcus (GBS) Trivalent Vaccine (not requiring reconstitution prior to administration), and of the lyophilized formulation of GBS Trivalent Vaccine, administered in non-pregnant and pregnant women in the clinical development program to date.

Infections, StreptococcalStreptococcal Infections

GlaxoSmithKline1,053 participantsStarted Nov 2014

Redding, California, United States • Lenexa, Kansas, United States • Baltimore, Maryland, United States +6 more locations

COMPLETEDPhase 3< 1 mile

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

NCT02065791

The goal of this study is to assess whether canagliflozin has a renal and vascular protective effect in reducing the progression of renal impairment relative to placebo in participants with type 2 diabetes mellitus (T2DM), Stage 2 or 3 chronic kidney disease (CKD) and macroalbuminuria, who are receiving standard of care including a maximum tolerated labeled daily dose of an angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB).

Diabetes Mellitus, Type 2Diabetic Nephropathy

Janssen Research & Development, LLC4,401 participantsStarted Feb 2014

Birmingham, Alabama, United States • Montgomery, Alabama, United States • Tempe, Arizona, United States +572 more locations

Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

Find Trials by Condition in Salt Lake City

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

ImageReady(TM) MR Conditional Pacing System Clinical Study

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Evaluation of the Safety and Effectiveness of the DuraHeart™ LVAS

Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis

Studies in Families With Corneal Dystrophy or Other Inherited Corneal Diseases

Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer

Post Market Surveillance Study of the Wingspan Stent System

Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Safety and Efficacy of PRP for Treatment of Disc Pain

Design Validation of Senofilcon A With New UV-blocking Additive

HW006 LATERAL Thoracotomy

Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML)

Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients

A Clinical Trial of IntensiVE Dialysis